Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer.

Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer. Abstract Text:

    w b growdonW B Growdon,e lopez-varelaE Lopez-Varela,r littellR Littell,e olivaE Oliva,m seidenM Seiden,c krasnerC Krasner,h leeH Lee,a fullerA Fuller,

    Central nervous system metastasis from gynecological malignancy is a rare phenomenon that has been described in the past 30 years. The objective of this study is to analyze the treatment modalities and prognostic factors for brain metastases from gynecological tumors that predict prolonged survival. A retrospective chart and pathology review of 47 patients diagnosed with a gynecological tumor with brain metastasis in 1994-2004 was performed. Thirty patients had undergone initial diagnosis and treatment at our institution, and 17 patients were referred following primary treatment at an outside institution. Adjusted Chi-square, Kaplan-Meier survival estimates, log-rank tests, and Cox regression analysis were utilized for statistical analysis of the total cohort. Of the 3146 patients with newly diagnosed gynecological cancer in this 10-year period, 30 developed brain metastasis demonstrating an incidence of 0.95%. Overall median survival from the time of diagnosis of brain metastasis was 7.5 months (95% CI 4-15, range 9 days-64 months) and 40% survival at 1 year. Multivariate analysis revealed evidence of extracranial disease at time of metastasis diagnosis predicted decreased survival (hazard ratio 6.207), while papillary serous histology (hazard ratio 0.42), and use of any chemotherapy (hazard ratio 0.24) predicted longer survival. No other patient or tumor characteristics were found to be independent prognostic indicators affecting survival. Despite the ominous prognosis associated with the development of brain metastasis, these retrospective data suggest that multimodal therapy with whole brain radiation therapy, chemotherapy, and surgical resection of metastases in selected patients without evidence of extracranial and with solitary or multiple lesions can prolong survival.

    Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer. Publishing Authors By Initials

    wb growdonWB Growdon,e lopez-varelaE Lopez-Varela,r littellR Littell,e olivaE Oliva,m seidenM Seiden,c krasnerC Krasner,h leeH Lee,a fullerA Fuller,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE: 2008 Mar-Apr

    Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: International journal of gynecological cancer : of

    VOLUME: 18

    Page Numbers: 262-8

    Journal Abbreviation:

    ISSN: 1525-1438

    DAY: 22

    MONTH: 06

    YEAR: 2007

    Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9111626

    Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer.

    AFFILIATION: Division of Gynecology Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Int J Gynecol Cancer

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News